1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. SELECTA BIOSCIENCES INC

Selecta Biosciences Inc

XNAS: SELB

Expensive Underperformer

Watchlist

Portfolio

Share


Insider Trading disclosures for Selecta Biosciences Inc

The latest disclosure was made by Carsten Brunn in Selecta Biosciences Inc where a trade of 4,654,100 Common Stock done was reported to US exchanges on Jan. 2, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Carsten Brunn Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 4,654,100 4,916,056 (5%) 5% 0 Common Stock
Kalayoglu Murat Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 228,000 228,000 - - Stock Option (Right to Buy)
Sallin Aymeric Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 228,000 228,000 - - Stock Option (Right to Buy)
Jewell Christopher M. Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 778,200 778,200 (0%) 0% 0 Common Stock
Jewell M. Christopher Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 998,000 998,000 - - Employee Stock Option (right to buy)
Davis Blaine Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 3,110,000 3,110,000 - - Employee Stock Option (right to buy)
C. Timothy Barabe Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 178,000 428,013 (0%) 0% 0 Common Stock
Zenner J. Patrick Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 228,000 228,000 - - Stock Option (Right to Buy)
S. Carrie Cox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 248,000 248,000 - - Stock Option (Right to Buy)
Carrie Cox S. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 178,000 390,881 (0%) 0% 0 Common Stock
Sallin Aymeric Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 178,000 178,000 (0%) 0% 0 Common Stock
Kurtoglu Metin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 1,531,000 1,531,000 (1%) 1% 0 Common Stock
Zenner Patrick J. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 178,000 233,248 (0%) 0% 0 Common Stock
Timothy Springer A. Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 228,000 228,000 - - Stock Option (Right to Buy)
Timothy Springer A. Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 178,000 7,471,625 (8%) 0% 0 Common Stock
Nishan de Silva Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 178,000 185,000 (0%) 0% 0 Common Stock
Milos Miljkovic Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 548,200 548,200 (0%) 0% 0 Common Stock
Kalayoglu Murat Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 178,000 435,739 (0%) 0% 0 Common Stock
Carsten Brunn Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 5,971,000 5,971,000 - - Employee Stock Option (right to buy)
de Silva Nishan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 228,000 228,000 - - Stock Option (Right to Buy)
Barabe Timothy C. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 228,000 228,000 - - Stock Option (Right to Buy)
Davis Blaine Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 2,424,000 2,424,000 (2%) 2% 0 Common Stock
Kurtoglu Metin Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 1,965,000 1,965,000 - - Employee Stock Option (right to buy)
Miljkovic Milos Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 703,000 703,000 - - Employee Stock Option (right to buy)
Michael Singer Director, Ten Percent Owner Gift of securities by or to the insider at price $ 0.00 per share. 22 Dec 2023 3,000 3,304 - - Series A Convertible Preferred Stock
Singer Michael Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Dec 2023 228,000 228,000 - - Stock Option (Right to Buy)
Michael Singer Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Dec 2023 178,000 288,123 (0%) 0% 0 Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Gift of securities by or to the insider at price $ 0.00 per share. 30 May 2023 43,000 321,316 (0%) 0% 0 Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Gift of securities by or to the insider at price $ 0.00 per share. 30 May 2023 26,500 225,316 (0%) 0% 0 Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Gift of securities by or to the insider at price $ 0.00 per share. 30 May 2023 26,500 251,816 (0%) 0% 0 Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Gift of securities by or to the insider at price $ 0.00 per share. 30 May 2023 43,000 278,316 (0%) 0% 0 Common Stock
Peter G. Traber Chief Medical Officer Sale of securities on an exchange or to another person at price $ 1.13 per share. 04 Jan 2023 3,445 446,141 (0%) 0% 1.1 3,890 Common Stock
Peter G. Traber Chief Medical Officer Sale of securities on an exchange or to another person at price $ 1.13 per share. 04 Jan 2023 8,164 449,601 (0%) 0% 1.1 9,256 Common Stock
Peter G. Traber Chief Medical Officer Sale of securities on an exchange or to another person at price $ 1.13 per share. 04 Jan 2023 15 449,586 (0%) 0% 1.1 17 Common Stock
Peter G. Traber Chief Medical Officer Sale of securities on an exchange or to another person at price $ 1.10 per share. 04 Jan 2023 20 446,121 (0%) 0% 1.1 22 Common Stock
Lloyd Johnston Chief Operations Officer Sale of securities on an exchange or to another person at price $ 1.10 per share. 04 Jan 2023 20 265,515 (0%) 0% 1.1 22 Common Stock
Lloyd Johnston Chief Operations Officer Sale of securities on an exchange or to another person at price $ 1.13 per share. 04 Jan 2023 6,381 268,918 (0%) 0% 1.1 7,234 Common Stock
Lloyd Johnston Chief Operations Officer Sale of securities on an exchange or to another person at price $ 1.18 per share. 04 Jan 2023 11 268,907 (0%) 0% 1.2 13 Common Stock
Lloyd Johnston Chief Operations Officer Sale of securities on an exchange or to another person at price $ 1.13 per share. 04 Jan 2023 3,372 265,535 (0%) 0% 1.1 3,808 Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 1.18 per share. 04 Jan 2023 11 367,708 (0%) 0% 1.2 13 Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 1.10 per share. 04 Jan 2023 20 364,316 (0%) 0% 1.1 22 Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 1.13 per share. 04 Jan 2023 6,381 367,719 (0%) 0% 1.1 7,234 Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 1.13 per share. 04 Jan 2023 3,372 364,336 (0%) 0% 1.1 3,808 Common Stock
Carsten Brunn Director, President and CEO Sale of securities on an exchange or to another person at price $ 1.12 per share. 04 Jan 2023 77 786,013 (0%) 0% 1.1 86 Common Stock
Carsten Brunn Director, President and CEO Sale of securities on an exchange or to another person at price $ 1.13 per share. 04 Jan 2023 27,549 799,534 (0%) 0% 1.1 31,232 Common Stock
Carsten Brunn Director, President and CEO Sale of securities on an exchange or to another person at price $ 1.15 per share. 04 Jan 2023 48 799,486 (0%) 0% 1.1 55 Common Stock
Carsten Brunn Director, President and CEO Sale of securities on an exchange or to another person at price $ 1.13 per share. 04 Jan 2023 13,396 786,090 (0%) 0% 1.1 15,128 Common Stock
Carrie S. Cox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 107,500 107,500 - - Stock Option (Right to Buy)
Patrick J. Zenner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 75,000 75,000 - - Stock Option (Right to Buy)
Peter G. Traber Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 200,000 457,765 (0%) 0% 0 Common Stock
Peter G. Traber Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 900,000 900,000 - - Employee Stock Option (right to buy)
Scott D. Myers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 87,500 87,500 - - Stock Option (Right to Buy)
Timothy C. Barabe Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 87,500 87,500 - - Stock Option (Right to Buy)
Nishan de Silva Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 75,000 75,000 - - Stock Option (Right to Buy)
Lloyd Johnston Chief Operations Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 475,000 475,000 - - Employee Stock Option (right to buy)
Lloyd Johnston Chief Operations Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 100,000 275,299 (0%) 0% 0 Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 100,000 374,100 (0%) 0% 0 Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 475,000 475,000 - - Employee Stock Option (right to buy)
Aymeric Sallin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 75,000 75,000 - - Stock Option (Right to Buy)
Timothy A. Springer Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 75,000 75,000 - - Stock Option (Right to Buy)
Carsten Brunn Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 282,800 827,083 (0%) 0% 0 Common Stock
Carsten Brunn Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2023 1,275,000 1,275,000 - - Employee Stock Option (right to buy)
Carsten Brunn Director, President and CEO Sale of securities on an exchange or to another person at price $ 1.33 per share. 05 Dec 2022 4,522 544,283 (0%) 0% 1.3 6,014 Common Stock
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2022 10,938 0 - - Restricted Stock Units
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2022 10,938 548,805 (0%) 0% 0 Common Stock
Blaine Davis Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Nov 2022 1,250,000 1,250,000 - - Employee Stock Option (right to buy)
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Sep 2022 10,937 545,327 (0%) 0% 0 Common Stock
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Sep 2022 10,937 10,938 - - Restricted Stock Units
Carsten Brunn Director, President and CEO Sale of securities on an exchange or to another person at price $ 1.85 per share. 01 Sep 2022 4,768 540,559 (0%) 0% 1.8 8,810 Common Stock
Carrie S. Cox Director Purchase of securities on an exchange or from another person at price $ 1.15 per share. 13 Jun 2022 130,000 212,881 (0%) 0% 1.2 149,799 Common Stock
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jun 2022 10,938 21,875 - - Restricted Stock Units
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jun 2022 10,938 534,390 (0%) 0% 0 Common Stock
Timothy A. Springer Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Apr 2022 5,011,200 5,011,200 - - Warrant (right to buy)
Timothy A. Springer Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 11 Apr 2022 6,681,600 29,868,490 (34%) 7% - Common Stock
Carsten Brunn Director, President and CEO Sale of securities on an exchange or to another person at price $ 1.81 per share. 01 Mar 2022 5,443 523,452 (0%) 0% 1.8 9,863 Common Stock
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2022 10,937 32,813 - - Restricted Stock Units
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2022 10,937 528,895 (0%) 0% 0 Common Stock
Timothy C. Barabe Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Jan 2022 10,000 0 - - Stock Option (Right to Buy)
Timothy C. Barabe Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.10 per share. 14 Jan 2022 10,000 200,013 (0%) 0% 2.1 21,000 Common Stock
Peter G. Traber Chief Medical Officer Sale of securities on an exchange or to another person at price $ 3.09 per share. 05 Jan 2022 3,226 251,355 (0%) 0% 3.1 9,955 Common Stock
Lloyd Johnston Chief Operations Officer Sale of securities on an exchange or to another person at price $ 3.09 per share. 05 Jan 2022 3,416 175,299 (0%) 0% 3.1 10,541 Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 3.09 per share. 05 Jan 2022 3,416 268,353 (0%) 0% 3.1 10,541 Common Stock
Carsten Brunn Director, President and CEO Sale of securities on an exchange or to another person at price $ 3.09 per share. 05 Jan 2022 13,597 517,958 (0%) 0% 3.1 41,959 Common Stock
Carrie S. Cox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 60,000 60,000 - - Stock Option (Right to Buy)
Patrick J. Zenner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 40,000 40,000 - - Stock Option (Right to Buy)
Peter G. Traber Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 90,200 254,581 (0%) 0% 0 Common Stock
Peter G. Traber Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 415,900 415,900 - - Employee Stock Option (right to buy)
Scott D. Myers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 40,000 40,000 - - Stock Option (Right to Buy)
Timothy C. Barabe Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 40,000 40,000 - - Stock Option (Right to Buy)
Nishan de Silva Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 40,000 40,000 - - Stock Option (Right to Buy)
Lloyd Johnston Chief Operations Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 340,000 340,000 - - Employee Stock Option (right to buy)
Lloyd Johnston Chief Operations Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 72,000 178,715 (0%) 0% 0 Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 340,000 340,000 - - Employee Stock Option (right to buy)
Takashi Kei Kishimoto Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 72,000 271,769 (0%) 0% 0 Common Stock
Aymeric Sallin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 40,000 40,000 - - Stock Option (Right to Buy)
Timothy A. Springer Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 40,000 40,000 - - Stock Option (Right to Buy)
Carsten Brunn Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 1,056,100 1,056,100 - - Employee Stock Option (right to buy)
Carsten Brunn Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 226,300 531,555 (0%) 0% 0 Common Stock
Kevin Tan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 340,000 340,000 - - Employee Stock Option (right to buy)
Kevin Tan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Jan 2022 72,000 77,000 (0%) 0% 0 Common Stock
Peter G. Traber Chief Medical Officer Sale of securities on an exchange or to another person at price $ 2.99 per share. 10 Dec 2021 4,083 164,381 (0%) 0% 3.0 12,196 Common Stock
Lloyd Johnston Chief Operations Officer Sale of securities on an exchange or to another person at price $ 2.99 per share. 10 Dec 2021 4,370 106,715 (0%) 0% 3.0 13,053 Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 2.99 per share. 10 Dec 2021 4,370 199,769 (0%) 0% 3.0 13,053 Common Stock
Carsten Brunn Director, President and CEO Sale of securities on an exchange or to another person at price $ 2.99 per share. 10 Dec 2021 17,196 305,255 (0%) 0% 3.0 51,363 Common Stock
Timothy A. Springer Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.99 per share. 09 Dec 2021 58,681 22,961,108 (26%) 0% 3.0 175,439 Common Stock
Timothy A. Springer Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 3.06 per share. 09 Dec 2021 3,748,000 22,902,427 (26%) 4% 3.1 11,468,880 Common Stock
Timothy A. Springer Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.98 per share. 09 Dec 2021 14,592 22,975,700 (26%) 0% 3.0 43,491 Common Stock
Peter G. Traber Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2021 13,750 168,464 (0%) 0% 0 Common Stock
Lloyd Johnston Chief Operations Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2021 13,750 111,085 (0%) 0% 0 Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2021 13,750 204,139 (0%) 0% 0 Common Stock
Carsten Brunn Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Dec 2021 37,500 322,451 (0%) 0% 0 Common Stock
Carrie S. Cox Director Purchase of securities on an exchange or from another person at price $ 2.95 per share. 03 Dec 2021 17,200 82,881 (0%) 0% 2.9 50,664 Common Stock
Nishan de Silva Director Purchase of securities on an exchange or from another person at price $ 2.96 per share. 02 Dec 2021 7,000 7,000 (0%) 0% 3.0 20,723 Common Stock
Kevin Tan Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 3.03 per share. 02 Dec 2021 5,000 5,000 (0%) 0% 3.0 15,127 Common Stock
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2021 10,938 289,697 (0%) 0% 0 Common Stock
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2021 10,938 43,750 - - Restricted Stock Units
Carsten Brunn Director, President and CEO Sale of securities on an exchange or to another person at price $ 2.96 per share. 01 Dec 2021 4,746 284,951 (0%) 0% 3.0 14,065 Common Stock
Peter G. Traber Chief Medical Officer Sale of securities on an exchange or to another person at price $ 4.39 per share. 13 Oct 2021 3,636 154,714 (0%) 0% 4.4 15,962 Common Stock
Lloyd Johnston Chief Operations Officer Sale of securities on an exchange or to another person at price $ 4.39 per share. 13 Oct 2021 3,892 97,335 (0%) 0% 4.4 17,086 Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 4.39 per share. 13 Oct 2021 3,892 190,389 (0%) 0% 4.4 17,086 Common Stock
Carsten Brunn Director, President and CEO Sale of securities on an exchange or to another person at price $ 4.39 per share. 13 Oct 2021 15,313 278,759 (0%) 0% 4.4 67,224 Common Stock
Peter G. Traber Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2021 13,750 158,350 (0%) 0% 0 Common Stock
Lloyd Johnston Chief Operations Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2021 13,750 101,227 (0%) 0% 0 Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2021 13,750 194,281 (0%) 0% 0 Common Stock
Carsten Brunn Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2021 37,500 294,072 (0%) 0% 0 Common Stock
Peter G. Traber Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Sep 2021 9,100 144,600 (0%) 0% 0 Common Stock
Peter G. Traber Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Sep 2021 54,400 54,400 - - Employee Stock Option (right to buy)
Carsten Brunn Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Sep 2021 27,200 256,572 (0%) 0% 0 Common Stock
Carsten Brunn Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Sep 2021 163,000 163,000 - - Employee Stock Option (right to buy)
Kevin Tan Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Sep 2021 750,000 750,000 - - Employee Stock Option (right to buy)
Carsten Brunn Director, President and CEO Sale of securities on an exchange or to another person at price $ 4.51 per share. 01 Sep 2021 4,523 229,372 (0%) 0% 4.5 20,399 Common Stock
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Sep 2021 10,937 54,688 - - Restricted Stock Units
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Sep 2021 10,937 233,895 (0%) 0% 0 Common Stock
Timothy C. Barabe Director Purchase of securities on an exchange or from another person at price $ 4.00 per share. 18 Aug 2021 9,000 190,013 (0%) 0% 4 36,000 Common Stock
Nishan de Silva Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2021 80,000 80,000 - - Stock Option (Right to Buy)
Carsten Brunn Director, President and CEO Sale of securities on an exchange or to another person at price $ 4.38 per share. 01 Jun 2021 4,806 222,958 (0%) 0% 4.4 21,041 Common Stock
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jun 2021 10,938 227,764 (0%) 0% 0 Common Stock
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jun 2021 10,938 65,625 - - Restricted Stock Units
Peter G. Traber Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 3.99 per share. 26 May 2021 20,000 135,500 (0%) 0% 4.0 79,850 Common Stock
Peter G. Traber Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 3.32 per share. 24 May 2021 12,500 110,500 (0%) 0% 3.3 41,498 Common Stock
Peter G. Traber Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 3.48 per share. 24 May 2021 5,000 115,500 (0%) 0% 3.5 17,400 Common Stock
Timothy A. Springer Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 4.00 per share. 24 May 2021 926,170 19,154,427 (22%) 1% 4.0 3,705,699 Common Stock
Timothy A. Springer Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 3.55 per share. 24 May 2021 383,830 18,228,257 (21%) 0% 3.5 1,362,098 Common Stock
Timothy A. Springer Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 3.38 per share. 24 May 2021 590,000 17,844,427 (20%) 0% 3.4 1,992,076 Common Stock
Timothy A. Springer Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 3.19 per share. 21 May 2021 2,773,479 17,254,427 (19%) 3% 3.2 8,847,398 Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 May 2021 13,629 0 - - Employee Stock Option (right to buy)
Takashi Kei Kishimoto Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.77 per share. 07 May 2021 13,629 177,778 (0%) 0% 2.8 37,752 Common Stock
Carrie S. Cox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2021 60,000 60,000 - - Stock Option (Right to Buy)
Patrick J. Zenner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2021 40,000 40,000 - - Stock Option (Right to Buy)
Scott D. Myers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2021 40,000 40,000 - - Stock Option (Right to Buy)
Timothy C. Barabe Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2021 40,000 40,000 - - Stock Option (Right to Buy)
Aymeric Sallin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2021 40,000 40,000 - - Stock Option (Right to Buy)
Timothy A. Springer Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2021 40,000 40,000 - - Stock Option (Right to Buy)
Timothy C. Barabe Director Purchase of securities on an exchange or from another person at price $ 4.10 per share. 26 Mar 2021 10,000 181,013 (0%) 0% 4.1 41,000 Common Stock
Peter G. Traber Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 4.50 per share. 17 Mar 2021 10,000 98,000 (0%) 0% 4.5 45,000 Common Stock
Peter G. Traber Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 4.53 per share. 17 Mar 2021 10,000 88,000 (0%) 0% 4.5 45,295 Common Stock
Lloyd Johnston COO and SVP, R&D Sale of securities on an exchange or to another person at price $ 4.45 per share. 17 Mar 2021 15,128 87,477 (0%) 0% 4.4 67,312 Common Stock
Carsten Brunn Director, President and CEO Sale of securities on an exchange or to another person at price $ 4.26 per share. 01 Mar 2021 5,461 216,826 (0%) 0% 4.3 23,257 Common Stock
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2021 10,937 76,563 - - Restricted Stock Units
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2021 10,937 222,287 (0%) 0% 0 Common Stock
Lloyd Johnston COO and SVP, R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 11 Feb 2021 44,871 0 - - Employee Stock Option (right to buy)
Lloyd Johnston COO and SVP, R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.63 per share. 11 Feb 2021 44,871 102,605 (0%) 0% 0.6 28,269 Common Stock
Peter G. Traber Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 230,000 230,000 - - Employee Stock Option (right to buy)
Peter G. Traber Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 38,000 78,000 (0%) 0% 0 Common Stock
Lloyd Johnston COO and SVP, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 38,000 57,734 (0%) 0% 0 Common Stock
Lloyd Johnston COO and SVP, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 230,000 230,000 - - Employee Stock Option (right to buy)
Takashi Kei Kishimoto Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 230,000 230,000 - - Employee Stock Option (right to buy)
Takashi Kei Kishimoto Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 38,000 164,149 (0%) 0% 0 Common Stock
Carsten Brunn Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 670,000 670,000 - - Employee Stock Option (right to buy)
Carsten Brunn Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 110,000 211,350 (0%) 0% 0 Common Stock
Bradford D. Dahms Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 230,000 230,000 - - Employee Stock Option (right to buy)
Bradford D. Dahms Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jan 2021 38,000 38,000 (0%) 0% 0 Common Stock
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2020 10,938 87,500 - - Restricted Stock Units
Carsten Brunn Director, President and CEO Sale of securities on an exchange or to another person at price $ 3.35 per share. 01 Dec 2020 3,323 101,350 (0%) 0% 3.4 11,134 Common Stock
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2020 10,938 104,673 (0%) 0% 0 Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.77 per share. 23 Oct 2020 30,000 126,149 (0%) 0% 2.8 83,100 Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Oct 2020 30,000 13,629 - - Employee Stock Option (right to buy)
Timothy A. Springer Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.63 per share. 21 Oct 2020 1,770,204 13,486,460 (15%) 2% 2.6 4,656,699 Common Stock
Timothy A. Springer Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.71 per share. 21 Oct 2020 994,488 14,480,948 (16%) 1% 2.7 2,699,737 Common Stock
Timothy A. Springer Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.50 per share. 21 Oct 2020 880,000 11,716,256 (13%) 1% 2.5 2,199,472 Common Stock
Timothy A. Springer Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.36 per share. 16 Oct 2020 759,500 9,926,256 (11%) 0% 2.4 1,795,002 Common Stock
Timothy A. Springer Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.21 per share. 16 Oct 2020 910,000 10,836,256 (12%) 1% 2.2 2,013,193 Common Stock
Timothy A. Springer Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.42 per share. 16 Oct 2020 218,196 9,166,756 (10%) 0% 2.4 528,034 Common Stock
Timothy A. Springer Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 2.00 per share. 09 Oct 2020 276,703 8,948,560 (10%) 0% 2.0 552,465 Common Stock
Timothy C. Barabe Director Purchase of securities on an exchange or from another person at price $ 1.68 per share. 06 Oct 2020 50,000 171,013 (0%) 0% 1.7 83,985 Common Stock
Timothy A. Springer Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.89 per share. 06 Oct 2020 530,441 8,671,857 (10%) 0% 1.9 1,000,836 Common Stock
Timothy A. Springer Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.65 per share. 06 Oct 2020 654,953 8,141,416 (9%) 0% 1.6 1,078,577 Common Stock
Timothy A. Springer Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.68 per share. 06 Oct 2020 2,000,000 7,486,463 (8%) 2% 1.7 3,365,800 Common Stock
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Sep 2020 10,937 97,099 (0%) 0% 0 Common Stock
Carsten Brunn Director, President and CEO Sale of securities on an exchange or to another person at price $ 2.39 per share. 01 Sep 2020 3,364 93,735 (0%) 0% 2.4 8,035 Common Stock
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Sep 2020 10,937 98,438 - - Restricted Stock Units
Lloyd Johnston COO & SVP, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2020 40,000 40,000 - - Employee Stock Option (right to buy)
Carsten Brunn Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2020 75,000 75,000 - - Employee Stock Option (right to buy)
Bradford D. Dahms Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jul 2020 40,000 40,000 - - Employee Stock Option (right to buy)
Timothy C. Barabe Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.46 per share. 24 Jun 2020 32,840 121,013 (0%) 0% 1.5 47,946 Common Stock
Timothy C. Barabe Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 24 Jun 2020 32,840 0 - - Common Warrants
Carrie S. Cox Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2020 30,000 30,000 - - Stock Option (Right to Buy)
Patrick J. Zenner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2020 20,000 20,000 - - Stock Option (Right to Buy)
Scott Myers Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2020 20,000 20,000 - - Stock Option (Right to Buy)
Timothy C. Barabe Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2020 20,000 20,000 - - Stock Option (Right to Buy)
Aymeric Sallin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2020 20,000 20,000 - - Stock Option (Right to Buy)
Timothy A. Springer Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jun 2020 20,000 20,000 - - Stock Option (Right to Buy)
Carsten Brunn Director, President and CEO Sale of securities on an exchange or to another person at price $ 3.86 per share. 01 Jun 2020 3,253 86,162 (0%) 0% 3.9 12,557 Common Stock
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jun 2020 10,938 109,375 - - Restricted Stock Units
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jun 2020 10,938 89,415 (0%) 0% 0 Common Stock
Timothy C. Barabe Director Purchase of securities on an exchange or from another person at price $ 2.00 per share. 17 Mar 2020 5,000 88,173 (0%) 0% 2 10,000 Common Stock
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2020 10,937 120,313 - - Restricted Stock Units
Carsten Brunn Director, President and CEO Sale of securities on an exchange or to another person at price $ 3.86 per share. 01 Mar 2020 3,374 78,477 (0%) 0% 3.9 13,011 Common Stock
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Mar 2020 10,937 81,851 (0%) 0% 0 Common Stock
Lloyd Johnston COO and SVP, R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.47 per share. 16 Jan 2020 5,128 16,734 (0%) 0% 0.5 2,410 Common Stock
Lloyd Johnston COO and SVP, R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Jan 2020 5,128 0 - - Employee Stock Option (right to buy)
Elona Kogan General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2020 140,000 140,000 - - Employee Stock Option (right to buy)
Lloyd Johnston COO and SVP, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2020 140,000 140,000 - - Employee Stock Option (right to buy)
Takashi Kei Kishimoto Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2020 140,000 140,000 - - Employee Stock Option (right to buy)
Stephen Smolinski Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2020 100,000 100,000 - - Employee Stock Option (right to buy)
Carsten Brunn Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2020 600,000 600,000 - - Employee Stock Option (right to buy)
Alison D. Schecter Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2020 100,000 100,000 - - Employee Stock Option (right to buy)
Bradford D. Dahms Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2020 140,000 140,000 - - Employee Stock Option (right to buy)
Carrie S. Cox None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2019 32,840 32,840 - - Warrants
Carrie S. Cox None Grant, award, or other acquisition of securities at price $ 1.46 per share. 23 Dec 2019 65,681 65,681 (0%) 0% 1.5 95,894 Common Stock
Scott Myers None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2019 19,704 19,704 - - Warrants
Scott Myers None Grant, award, or other acquisition of securities at price $ 1.46 per share. 23 Dec 2019 39,409 80,845 (0%) 0% 1.5 57,537 Common Stock
Timothy C. Barabe None Grant, award, or other acquisition of securities at price $ 1.46 per share. 23 Dec 2019 65,681 83,173 (0%) 0% 1.5 95,894 Common Stock
Timothy C. Barabe None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2019 32,840 32,840 - - Warrants
Timothy A. Springer Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Dec 2019 1,970,443 1,970,443 - - Warrants
Timothy A. Springer Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 1.46 per share. 23 Dec 2019 3,940,887 5,486,463 (6%) 4% 1.5 5,753,695 Common Stock
Timothy A. Springer Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 12 Dec 2019 1,237,028 7,293,625 (8%) 2% 0 Common Stock
Carsten Brunn Director, President and CEO Sale of securities on an exchange or to another person at price $ 1.53 per share. 01 Dec 2019 14,272 70,914 (0%) 0% 1.5 21,809 Common Stock
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2019 43,750 131,250 - - Restricted Stock Units
Carsten Brunn Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Dec 2019 43,750 85,186 (0%) 0% 0 Common Stock
Carrie S. Cox None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Nov 2019 20,000 20,000 - - Stock Option (Right to Buy)
Lloyd Johnston COO and SVP, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Oct 2019 180,000 180,000 - - Employee Stock Option (right to buy)
Takashi Kei Kishimoto Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Oct 2019 180,000 180,000 - - Employee Stock Option (right to buy)
Stephen Smolinski Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Oct 2019 180,000 180,000 - - Employee Stock Option (right to buy)
Carsten Brunn Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Oct 2019 400,000 400,000 - - Employee Stock Option (right to buy)
Timothy A. Springer Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 03 Sep 2019 1,237,028 0 (0%) 2% 0 Common Stock
Bradford D. Dahms Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Sep 2019 400,000 400,000 - - Employee Stock Option (right to buy)
Patrick J. Zenner None Grant, award, or other acquisition of securities at price $ 1.81 per share. 20 Aug 2019 55,248 55,248 (0%) 0% 1.8 99,999 Common Stock
Scott Myers None Grant, award, or other acquisition of securities at price $ 1.81 per share. 20 Aug 2019 41,436 41,436 (0%) 0% 1.8 74,999 Common Stock
Elona Kogan General Counsel Grant, award, or other acquisition of securities at price $ 1.81 per share. 20 Aug 2019 82,872 182,872 (0%) 0% 1.8 149,998 Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 1.81 per share. 20 Aug 2019 50,000 86,114 (0%) 0% 1.8 90,500 Common Stock
Timothy A. Springer Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 1.81 per share. 20 Aug 2019 1,600,000 6,056,597 (7%) 3% 1.8 2,896,000 Common Stock
Timothy A. Springer Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 1.81 per share. 20 Aug 2019 1,100,000 1,545,576 (1%) 2% 1.8 1,991,000 Common Stock
Stephen Smolinski Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 1.81 per share. 20 Aug 2019 13,812 13,812 (0%) 0% 1.8 25,000 Common Stock
Carsten Brunn Director, President and CEO Grant, award, or other acquisition of securities at price $ 1.81 per share. 20 Aug 2019 41,436 41,436 (0%) 0% 1.8 74,999 Common Stock
Timothy A. Springer Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 1.74 per share. 14 Aug 2019 10,000 86,418 (0%) 0% 1.7 17,415 Common Stock
Timothy C. Barabe None Purchase of securities on an exchange or from another person at price $ 1.72 per share. 13 Aug 2019 10,000 17,492 (0%) 0% 1.7 17,200 Common Stock
Lloyd Johnston COO and SVP, R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jul 2019 10,000 0 - - Employee Stock Option (right to buy)
Lloyd Johnston COO and SVP, R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.47 per share. 23 Jul 2019 10,000 11,606 (0%) 0% 0.5 4,700 Common Stock
Alison D. Schecter Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2019 350,000 350,000 - - Common Stock
Patrick J. Zenner None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2019 10,000 10,000 - - Stock Option (Right to Buy)
Scott Myers None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2019 20,000 20,000 - - Stock Option (Right to Buy)
Timothy C. Barabe None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2019 10,000 10,000 - - Stock Option (Right to Buy)
Amir H. Nashat None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2019 10,000 10,000 - - Stock Option (Right to Buy)
Omid Farokhzad None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2019 15,404 15,404 - - Stock Option (Right to Buy)
Aymeric Sallin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2019 10,000 10,000 - - Stock Option (Right to Buy)
Timothy A. Springer Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2019 10,000 10,000 - - Stock Option (Right to Buy)
Elona Kogan General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2019 400,000 400,000 - - Stock Option (Right to Buy)
Elona Kogan General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2019 100,000 100,000 (0%) 0% 0 Common Stock
Carsten Brunn Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2019 330,000 330,000 - - Employee Stock Option (right to buy)
Amir H. Nashat None Purchase of securities on an exchange or from another person at price $ 1.50 per share. 25 Jan 2019 7,711 18,329 (0%) 0% 1.5 11,567 Common Stock
Amir H. Nashat None Purchase of securities on an exchange or from another person at price $ 1.50 per share. 25 Jan 2019 1,125,756 2,676,234 (3%) 5% 1.5 1,688,634 Common Stock
Amir H. Nashat None Purchase of securities on an exchange or from another person at price $ 1.50 per share. 25 Jan 2019 11,258 26,760 (0%) 0% 1.5 16,887 Common Stock
Amir H. Nashat None Purchase of securities on an exchange or from another person at price $ 1.50 per share. 25 Jan 2019 21,941 52,156 (0%) 0% 1.5 32,912 Common Stock
Lloyd Johnston COO and SVP, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2019 100,000 100,000 - - Employee Stock Option (right to buy)
Takashi Kei Kishimoto Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2019 100,000 100,000 - - Employee Stock Option (right to buy)
Takashi Kei Kishimoto Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.77 per share. 07 Jan 2019 36,114 36,114 (0%) 0% 2.8 100,036 Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jan 2019 36,114 43,629 - - Employee Stock Option (right to buy)
Stephen Smolinski Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jan 2019 100,000 100,000 - - Employee Stock Option (right to buy)
Omid Farokhzad None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2018 75,000 75,000 - - Stock Option (Right to Buy)
Carsten Brunn Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2018 175,000 175,000 - - Restricted Stock Units
Carsten Brunn Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2018 1,000,000 1,000,000 - - Stock Option (Right to Buy)
Patrick J. Zenner None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2018 10,000 10,000 - - Stock Option (Right to Buy)
Peter Barton Hutt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2018 10,000 10,000 - - Stock Option (Right to Buy)
Timothy C. Barabe None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2018 10,000 10,000 - - Stock Option (Right to Buy)
Amir H. Nashat None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2018 10,000 10,000 - - Stock Option (Right to Buy)
John H. Leaman CFO, Treas. & Hd Corp Strategy Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2018 50,000 50,000 - - Stock Option (right to buy)
Omid Farokhzad None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2018 15,404 15,404 - - Stock Option (Right to Buy)
Lloyd Johnston COO and SVP, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2018 50,000 50,000 - - Stock Option (Right to Buy)
Takashi Kei Kishimoto Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2018 50,000 50,000 - - Stock Option (Right to Buy)
David Abraham GC, CCO & Corporate Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2018 25,000 25,000 - - Stock Option (Right to Buy)
Aymeric Sallin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2018 10,000 10,000 - - Stock Option (Right to Buy)
Timothy A. Springer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2018 10,000 10,000 - - Stock Option (Right to Buy)
Stephen Smolinski Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2018 80,000 80,000 - - Stock Option (Right to Buy)
Omid Farokhzad None Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 May 2018 95,000 95,000 - - Stock Option (Right to Buy)
John H. Leaman CFO, Treas. & Hd Corp Strategy Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Nov 2017 220,000 220,000 - - Stock Option (right to buy)
Earl Sands Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 10.26 per share. 17 Nov 2017 7,500 7,500 (0%) 0% 10.3 76,967 Common Stock
Stephen Smolinski Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Nov 2017 80,000 80,000 - - Stock Option (right to buy)
David Abraham GC, CCO & Corporate Secretary Purchase of securities on an exchange or from another person at price $ 9.25 per share. 14 Nov 2017 5,405 5,405 (0%) 0% 9.2 49,996 Common Stock
Timothy A. Springer None Purchase of securities on an exchange or from another person at price $ 9.27 per share. 14 Nov 2017 57,598 461,349 (2%) 0% 9.3 534,095 Common Stock
Werner Cautreels Director, President and CEO Purchase of securities on an exchange or from another person at price $ 9.31 per share. 13 Nov 2017 20,000 321,203 (1%) 0% 9.3 186,250 Common Stock
Timothy C. Barabe None Purchase of securities on an exchange or from another person at price $ 9.00 per share. 09 Nov 2017 2,500 7,492 (0%) 0% 9.0 22,505 Common Stock
Timothy C. Barabe None Purchase of securities on an exchange or from another person at price $ 9.73 per share. 09 Nov 2017 2,500 4,992 (0%) 0% 9.7 24,335 Common Stock
Timothy A. Springer None Purchase of securities on an exchange or from another person at price $ 9.78 per share. 09 Nov 2017 100 5,000 (0%) 0% 9.8 978 Common Stock
Timothy A. Springer None Purchase of securities on an exchange or from another person at price $ 9.33 per share. 09 Nov 2017 4,900 4,900 (0%) 0% 9.3 45,703 Common Stock
Timothy A. Springer None Purchase of securities on an exchange or from another person at price $ 9.74 per share. 09 Nov 2017 900 377,413 (1%) 0% 9.7 8,767 Common Stock
Timothy A. Springer None Purchase of securities on an exchange or from another person at price $ 9.33 per share. 09 Nov 2017 21,100 376,513 (1%) 0% 9.3 196,893 Common Stock
Timothy A. Springer None Purchase of securities on an exchange or from another person at price $ 9.03 per share. 09 Nov 2017 4,752 403,751 (1%) 0% 9.0 42,906 Common Stock
Timothy A. Springer None Purchase of securities on an exchange or from another person at price $ 9.04 per share. 09 Nov 2017 21,586 398,999 (1%) 0% 9.0 195,191 Common Stock
Amir H. Nashat None Sale of securities on an exchange or to another person at price $ 18.91 per share. 26 Sep 2017 1,321 30,215 (0%) 0% 18.9 24,982 Common Stock
Amir H. Nashat None Sale of securities on an exchange or to another person at price $ 18.91 per share. 26 Sep 2017 67,764 1,550,478 (7%) 0% 18.9 1,281,519 Common Stock
Amir H. Nashat None Sale of securities on an exchange or to another person at price $ 18.91 per share. 26 Sep 2017 677 15,502 (0%) 0% 18.9 12,803 Common Stock
Amir H. Nashat None Sale of securities on an exchange or to another person at price $ 18.91 per share. 26 Sep 2017 464 10,618 (0%) 0% 18.9 8,775 Common Stock
Amir H. Nashat None Sale of securities on an exchange or to another person at price $ 18.99 per share. 22 Sep 2017 35,872 1,618,242 (7%) 0% 19.0 681,141 Common Stock
Amir H. Nashat None Sale of securities on an exchange or to another person at price $ 18.99 per share. 22 Sep 2017 359 16,179 (0%) 0% 19.0 6,817 Common Stock
Amir H. Nashat None Sale of securities on an exchange or to another person at price $ 19.26 per share. 22 Sep 2017 278 11,327 (0%) 0% 19.3 5,355 Common Stock
Amir H. Nashat None Sale of securities on an exchange or to another person at price $ 19.26 per share. 22 Sep 2017 406 16,538 (0%) 0% 19.3 7,821 Common Stock
Amir H. Nashat None Sale of securities on an exchange or to another person at price $ 19.26 per share. 22 Sep 2017 40,562 1,654,114 (7%) 0% 19.3 781,386 Common Stock
Amir H. Nashat None Sale of securities on an exchange or to another person at price $ 18.99 per share. 22 Sep 2017 699 31,536 (0%) 0% 19.0 13,273 Common Stock
Amir H. Nashat None Sale of securities on an exchange or to another person at price $ 18.99 per share. 22 Sep 2017 245 11,082 (0%) 0% 19.0 4,652 Common Stock
Amir H. Nashat None Sale of securities on an exchange or to another person at price $ 19.26 per share. 22 Sep 2017 790 32,235 (0%) 0% 19.3 15,218 Common Stock
Amir H. Nashat None Sale of securities on an exchange or to another person at price $ 20.03 per share. 20 Sep 2017 282 12,295 (0%) 0% 20.0 5,648 Common Stock
Amir H. Nashat None Sale of securities on an exchange or to another person at price $ 20.03 per share. 20 Sep 2017 801 34,992 (0%) 0% 20.0 16,042 Common Stock
Amir H. Nashat None Sale of securities on an exchange or to another person at price $ 19.86 per share. 20 Sep 2017 100,911 1,694,676 (7%) 0% 19.9 2,004,022 Common Stock
Amir H. Nashat None Sale of securities on an exchange or to another person at price $ 19.86 per share. 20 Sep 2017 1,009 16,944 (0%) 0% 19.9 20,038 Common Stock
Amir H. Nashat None Sale of securities on an exchange or to another person at price $ 19.86 per share. 20 Sep 2017 690 11,605 (0%) 0% 19.9 13,703 Common Stock
Amir H. Nashat None Sale of securities on an exchange or to another person at price $ 19.86 per share. 20 Sep 2017 1,967 33,025 (0%) 0% 19.9 39,063 Common Stock
Amir H. Nashat None Sale of securities on an exchange or to another person at price $ 20.03 per share. 20 Sep 2017 41,116 1,795,587 (8%) 0% 20.0 823,467 Common Stock
Amir H. Nashat None Sale of securities on an exchange or to another person at price $ 20.03 per share. 20 Sep 2017 411 17,953 (0%) 0% 20.0 8,232 Common Stock
David Siewers CFO and Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Sep 2017 14,230 5,000 - - Employee Stock Option (right to buy)
David Siewers CFO and Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.63 per share. 20 Sep 2017 14,230 14,230 (0%) 0% 0.6 8,965 Common Stock
David Siewers CFO and Treasurer Sale of securities on an exchange or to another person at price $ 20.00 per share. 20 Sep 2017 2,194 0 (0%) 0% 20 43,880 Common Stock
David Siewers CFO and Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.63 per share. 20 Sep 2017 2,194 2,194 (0%) 0% 0.6 1,382 Common Stock
David Siewers CFO and Treasurer Sale of securities on an exchange or to another person at price $ 20.00 per share. 20 Sep 2017 14,230 0 (0%) 0% 20 284,600 Common Stock
David Siewers CFO and Treasurer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Sep 2017 2,194 0 - - Employee Stock Option (right to buy)
Werner Cautreels Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jul 2017 100,000 100,000 - - Stock Option (Right to Buy)
Earl Sands Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jul 2017 35,000 35,000 - - Stock Option (Right to Buy)
Lloyd Johnston COO & Senior VP, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jul 2017 45,000 45,000 - - Stock Option (Right to Buy)
Takashi Kei Kishimoto Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jul 2017 40,000 40,000 - - Stock Option (Right to Buy)
Peter Keller Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jul 2017 32,000 32,000 - - Stock Option (Right to Buy)
David Abraham GC and Corporate Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jul 2017 20,000 20,000 - - Stock Option (Right to Buy)
David Siewers CFO and Treasurer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jul 2017 20,000 20,000 - - Stock Option (Right to Buy)
Lloyd Johnston COO and SVP, R*D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Jul 2017 5,959 126 - - Employee Stock Option (right to buy)
Lloyd Johnston COO and SVP, R*D Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.77 per share. 03 Jul 2017 5,959 7,565 (0%) 0% 2.8 16,506 Common Stock
Lloyd Johnston COO and SVP, R*D Sale of securities on an exchange or to another person at price $ 19.74 per share. 03 Jul 2017 100 7,465 (0%) 0% 19.7 1,974 Common Stock
Lloyd Johnston COO and SVP, R*D Sale of securities on an exchange or to another person at price $ 19.09 per share. 03 Jul 2017 5,859 1,606 (0%) 0% 19.1 111,832 Common Stock
David Siewers Chief Financial Officer Sale of securities on an exchange or to another person at price $ 20.00 per share. 30 Jun 2017 7,420 0 (0%) 0% 20.0 148,405 Common Stock
David Siewers Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.63 per share. 30 Jun 2017 7,420 7,420 (0%) 0% 0.6 4,675 Common Stock
David Siewers Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Jun 2017 7,420 2,194 - - Employee Stock Option (right to buy)
David Siewers Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jun 2017 5,770 9,614 - - Employee Stock Option (right to buy)
David Siewers Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.63 per share. 29 Jun 2017 5,770 9,652 (0%) 0% 0.6 3,635 Common Stock
David Siewers Chief Financial Officer Sale of securities on an exchange or to another person at price $ 20.00 per share. 29 Jun 2017 9,616 36 (0%) 0% 20.0 192,322 Common Stock
David Siewers Chief Financial Officer Sale of securities on an exchange or to another person at price $ 20.00 per share. 29 Jun 2017 36 0 (0%) 0% 20 720 Common Stock
David Siewers Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Jun 2017 3,846 0 - - Employee Stock Option (right to buy)
David Siewers Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.47 per share. 29 Jun 2017 3,846 3,882 (0%) 0% 0.5 1,808 Common Stock
Peter Keller Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.63 per share. 27 Jun 2017 4,595 5,000 (0%) 0% 0.6 2,895 Common Stock
Peter Keller Chief Business Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jun 2017 4,595 89,588 - - Employee Stock Option (right to buy)
Peter Keller Chief Business Officer Sale of securities on an exchange or to another person at price $ 19.30 per share. 27 Jun 2017 4,595 405 (0%) 0% 19.3 88,681 Common Stock
Timothy A. Springer None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Jun 2017 79,130 79,130 - - Warrant (right to buy)
Timothy A. Springer None Purchase of securities on an exchange or from another person at price $ 17.71 per share. 27 Jun 2017 338,791 355,413 (1%) 1% 17.7 5,999,989 Common Stock
David Siewers Chief Financial Officer Sale of securities on an exchange or to another person at price $ 20.00 per share. 26 Jun 2017 6,886 36 (0%) 0% 20 137,720 Common Stock
Patrick J. Zenner None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2017 12,820 12,820 - - Stock Option (Right to Buy)
Peter Barton Hutt None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2017 6,410 6,410 - - Stock Option (Right to Buy)
Timothy C. Barabe None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2017 6,410 6,410 - - Stock Option (Right to Buy)
Amir H. Nashat None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2017 6,410 6,410 - - Stock Option (Right to Buy)
Omid Farokhzad None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2017 6,410 6,410 - - Stock Option (Right to Buy)
Aymeric Sallin None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2017 6,410 6,410 - - Stock Option (Right to Buy)
Timothy A. Springer None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2017 6,410 6,410 - - Stock Option (Right to Buy)
Lloyd Johnston COO and SVP, R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Jun 2017 10,512 10,000 - - Employee Stock Option (right to buy)
Lloyd Johnston COO and SVP, R&D Sale of securities on an exchange or to another person at price $ 17.04 per share. 15 Jun 2017 10,512 1,606 (0%) 0% 17.0 179,141 Common Stock
Lloyd Johnston COO and SVP, R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.47 per share. 15 Jun 2017 10,512 12,118 (0%) 0% 0.5 4,941 Common Stock
Timothy A. Springer None Purchase of securities on an exchange or from another person at price $ 13.75 per share. 01 Jun 2017 518 16,622 (0%) 0% 13.8 7,123 Common Stock
Timothy A. Springer None Purchase of securities on an exchange or from another person at price $ 14.01 per share. 17 May 2017 11,244 11,244 (0%) 0% 14.0 157,483 Common Stock
Timothy A. Springer None Purchase of securities on an exchange or from another person at price $ 14.00 per share. 17 May 2017 4,860 16,104 (0%) 0% 14 68,040 Common Stock
Edwin M. Kania None Sale of securities on an exchange or to another person at price $ 14.00 per share. 16 May 2017 266,795 560,067 (3%) 1% 14 3,735,130 Common Stock
Lloyd Johnston COO AND SVP, R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share. 17 Apr 2017 13,205 14,811 (0%) 0% 0.4 5,150 Common Stock
Lloyd Johnston COO AND SVP, R&D Sale of securities on an exchange or to another person at price $ 13.95 per share. 17 Apr 2017 13,205 1,606 (0%) 0% 14.0 184,210 Common Stock
Lloyd Johnston COO AND SVP, R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 17 Apr 2017 13,205 0 - - Employee Stock Option (right to buy)
Timothy C. Barabe None Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.00 per share. 27 Mar 2017 2,492 2,492 (0%) 0% 11 27,412 Common Stock
Timothy C. Barabe None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Mar 2017 2,492 10,328 - - Stock Option (Right to Buy)
Omid Farokhzad None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Mar 2017 51,981 9,932 - - Stock Option (right to buy)
Omid Farokhzad None Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.02 per share. 23 Mar 2017 8,019 188,004 (1%) 0% 7.0 56,293 Common Stock
Omid Farokhzad None Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.44 per share. 23 Mar 2017 51,981 179,985 (0%) 0% 3.4 178,815 Common Stock
Omid Farokhzad None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Mar 2017 8,019 17,622 - - Stock Option (right to buy)
Lloyd Johnston COO AND SVP, R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.39 per share. 23 Jan 2017 15,000 16,606 (0%) 0% 0.4 5,850 Common Stock
Lloyd Johnston COO AND SVP, R&D Sale of securities on an exchange or to another person at price $ 14.17 per share. 23 Jan 2017 3,890 1,606 (0%) 0% 14.2 55,121 Common Stock
Lloyd Johnston COO AND SVP, R&D Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 23 Jan 2017 15,000 13,205 - - Employee Stock Option (right to buy)
Lloyd Johnston COO AND SVP, R&D Sale of securities on an exchange or to another person at price $ 13.95 per share. 23 Jan 2017 11,110 5,496 (0%) 0% 14.0 154,985 Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 28 Dec 2016 10,000 0 - - Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Dec 2016 10,000 10,000 - - Common Stock
Takashi Kei Kishimoto Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Dec 2016 10,000 79,743 - - Employee Stock Option (right to buy)
David Abraham CCO, Gen.Counsel, Corp.Sec. Sale of securities on an exchange or to another person at price $ 0.00 per share. 21 Dec 2016 14,844 0 - - Common Stock
David Abraham CCO, Gen.Counsel, Corp.Sec. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Dec 2016 12,280 540 - - Employee Stock Option (right to buy)
David Abraham CCO, Gen.Counsel, Corp.Sec. Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Dec 2016 12,280 14,844 - - Common Stock
Peter Keller Chief Business Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Dec 2016 4,723 405 - - Common Stock
Timothy C. Barabe None Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Jul 2016 12,820 12,820 - - Stock Option (Right to Buy)
Carl L Gordon Director, Ten Percent Owner 27 Jun 2016 380,986 0 - - Series C Convertible Preferred Stock
Carl L Gordon Director, Ten Percent Owner 27 Jun 2016 4,351 0 - - Series E Convertible Preferred Stock
Carl L Gordon Director, Ten Percent Owner 27 Jun 2016 3,628 0 - - Series C Convertible Preferred Stock
Carl L Gordon Director, Ten Percent Owner 27 Jun 2016 456,870 0 - - Series E Convertible Preferred Stock
Carl L Gordon Director, Ten Percent Owner 27 Jun 2016 77,697 0 - - Series D Convertible Preferred Stock
Carl L Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Jun 2016 544,811 1,825,415 - - Common Stock
Carl L Gordon Director, Ten Percent Owner 27 Jun 2016 11,111 12,193 - - Common Stock
Carl L Gordon Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Jun 2016 5,189 17,382 - - Common Stock
Carl L Gordon Director, Ten Percent Owner 27 Jun 2016 1,166,884 1,280,604 - - Common Stock
Carl L Gordon Director, Ten Percent Owner 27 Jun 2016 739 0 - - Series D Convertible Preferred Stock
Edwin M. Kania None 27 Jun 2016 631,458 981,325 - - Common Stock
Edwin M. Kania None 27 Jun 2016 193,777 1,651,862 - - Common Stock
Edwin M. Kania None 27 Jun 2016 241,718 1,458,085 - - Common Stock
Edwin M. Kania None 27 Jun 2016 235,042 1,216,367 - - Common Stock
Edwin M. Kania None 27 Jun 2016 318,752 349,867 - - Common Stock
Edwin M. Kania None 27 Jun 2016 125,008 0 - - Series E Convertible Preferred Stock
Edwin M. Kania None 27 Jun 2016 241,718 0 - - Series D Convertible Preferred Stock
Edwin M. Kania None 27 Jun 2016 235,042 0 - - Series C Convertible Preferred Stock
Edwin M. Kania None 27 Jun 2016 631,458 0 - - Series B Convertible Preferred Stock
Edwin M. Kania None 27 Jun 2016 318,752 0 - - Series A Convertible Preferred Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 11,318 11,586 - - Common Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 1,652,646 1,691,963 - - Common Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 1,082 0 - - Series E Convertible Preferred Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 3,078 0 - - Series E Convertible Preferred Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 238,470 0 - - Series D Convertible Preferred Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 2,384 0 - - Series D Convertible Preferred Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 1,632 0 - - Series D Convertible Preferred Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 4,647 0 - - Series D Convertible Preferred Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 226,801 0 - - Series C Convertible Preferred Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 2,267 0 - - Series C Convertible Preferred Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 1,553 0 - - Series C Convertible Preferred Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 4,420 0 - - Series C Convertible Preferred Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 609,316 0 - - Series B Convertible Preferred Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 6,093 0 - - Series B Convertible Preferred Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 4,174 0 - - Series B Convertible Preferred Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 11,875 0 - - Series B Convertible Preferred Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 333,207 0 - - Series A Convertible Preferred Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 32,207 32,972 - - Common Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 16,524 16,916 - - Common Stock
Amir H. Nashat Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Jun 2016 2,821 35,793 - - Common Stock
Amir H. Nashat Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Jun 2016 991 12,577 - - Common Stock
Amir H. Nashat Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Jun 2016 1,448 18,364 - - Common Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 3,332 0 - - Series A Convertible Preferred Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 2,282 0 - - Series A Convertible Preferred Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 6,494 0 - - Series A Convertible Preferred Stock
Amir H. Nashat Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 27 Jun 2016 144,740 1,836,703 - - Common Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 157,957 0 - - Series E Convertible Preferred Stock
Amir H. Nashat Director, Ten Percent Owner 27 Jun 2016 1,579 0 - - Series E Convertible Preferred Stock
Omid Farokhzad None 27 Jun 2016 22,081 25,626 - - Common Stock
Omid Farokhzad None 27 Jun 2016 14,244 0 - - Series E Convertible Preferred Stock
Werner Cautreels Director, President and CEO, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2016 115,384 115,384 - - Stock Option (right to buy)
Earl Sands Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2016 53,999 53,999 - - Employee Stock Option (right to buy)
Lloyd Johnston COO and SVP, R&D Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2016 27,617 27,617 - - Employee Stock Option (right to buy)
Takashi Kei Kishimoto Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2016 24,512 24,512 - - Employee Stock Option (right to buy)
Peter Keller Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2016 30,841 30,841 - - Employee Stock Option (right to buy)
David Abraham CCO, GC and Corp. Sec. Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2016 28,760 28,760 - - Employee Stock Option (right to buy)
David Siewers Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2016 33,888 33,888 - - Employee Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters